---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-023805"
form_type: "8-K"
ticker: "JYNT"
cik: "0001612630"
company_name: "JOINT Corp"
filed_at: "2025-05-08T23:59:59+00:00"
generated_at: "2026-05-22T04:32:44.441541+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# The Joint Corp. Q1 revenue up 7% to $13.1M; net loss widens to $506k; reiterates 2025 guidance

## Summary
- Q1 revenue $13.1M (+7% YoY); system-wide sales $132.6M (+5%); comp sales 3%.
- Net loss from continuing ops $506k ($0.03/share) vs $399k in Q1 2024; adjusted EBITDA from continuing ops $46k vs $425k.
- Reiterated FY2025 guidance: system-wide sales $550-570M; consolidated adj. EBITDA $10-11.5M; new franchised clinics 30-40.
- Sold 9 franchise licenses; opened 5 franchised clinics; total clinics 969 (847 franchised).
- Transitioning to pure-play franchisor with digital marketing and pricing initiatives.

## SEC filing metadata
- accession: 0001628280-25-023805
- form_type: 8-K
- ticker: JYNT
- cik: 0001612630
- company_name: JOINT Corp
- filed_at: 2025-05-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/0001628280-25-023805-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1612630/000162828025023805/jynt-20250508.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-023805
- JSON: https://secwatch.observer/filing/0001628280-25-023805.json
- Plain text: https://secwatch.observer/filing/0001628280-25-023805.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.